A combination of Crestor (rosuvastatin) and ezetimibe reduced patients' LDL ("bad") cholesterol by 70 percent, says a recent clinical trial. The study also showed that after six weeks on the combination therapy, 94 percent of high-risk patients reached their cholesterol goals, versus 79 percent who were taking Crestor alone.
Read moreIf you finished taking tamoxifen for ER-receptive breast cancer even as long as 7 years ago, you might be able to do something right now to... Read more »
Tea is an ancient drink that dates back over 5,000 years. People have not only enjoyed its distinct taste but have also used it for... Read more »
It wasn’t too long ago that the annual mortality from HIV infection exceeded 20 percent/yr. Much to the credit of the scientific... Read more »
After writing the other week about the depressing research related to mortality rates of RA sufferers and the link to cardiovascular... Read more »
Most people think that if they are diagnosed with high cholesterol that a prescription medication is in their immediate future. This is... Read more »
Women who underwent psychological intervention during an initial bout of breast cancer handled the stress of recurrence and even had longer survival... Read more »
Researchers at the U.S. Centers for Disease Control and Prevention say only about 50 percent of American young adults have their cholesterol... Read more »
A new report from researchers at the U.S. Centers for Disease Control and Prevention has found that the number of people who have high levels of bad... Read more »
Older adults can cut their cholesterol levels by reducing their fat intake, researchers say, even if these adults are already taking statins to get... Read more »
Researchers have found that a combination of Crestor and Zetia cut bad cholesterol by 70 percent in a recent study. According to one researcher, the... Read more »